Stanford U. study: ADHD, other meds, show promise of Down Syndrome deficit reversal. The laboratory mice studies boosted levels of the neurotransmitter norepinephrine in mice engineered with DS-like genes. The meds had only short-term results, but may point the way to early therapy for humans. Click Reuters for full article.